Valenti L - Search Results

1

rs641738C>T near MBOAT7 is associated with liver fat, ALT and fibrosis in NAFLD: A meta-analysis.

Teo K, Abeysekera KWM, Adams L, Aigner E, Anstee QM, Banales JM, Banerjee R, Basu P, Berg T, Bhatnagar P, Buch S, Canbay A, Caprio S, Chatterjee A, Ida Chen YD, Chowdhury A, Daly AK, Datz C, de Gracia Hahn D, DiStefano JK, Dong J, Duret A; EU-PNAFLD Investigators; Emdin C, Fairey M, Gerhard GS; GOLD Consortium; Guo X, Hampe J, Hickman M, Heintz L, Hudert C, Hunter H, Kelly M, Kozlitina J, Krawczyk M, Lammert F, Langenberg C, Lavine J, Li L, Lim HK, Loomba R, Luukkonen PK, Melton PE, Mori TA, Palmer ND, Parisinos CA, Pillai SG, Qayyum F, Reichert MC, Romeo S, Rotter JI, Im YR, Santoro N, Schafmayer C, Speliotes EK, Stender S, Stickel F, Still CD, Strnad P, Taylor KD, Tybjærg-Hansen A, Umano GR, Utukuri M, Valenti L, Wagenknecht LE, Wareham NJ, Watanabe RM, Wattacheril J, Yaghootkar H, Yki-Järvinen H, Young KA, Mann JP. Teo K, et al. Among authors: valenti l. J Hepatol. 2021 Jan;74(1):20-30. doi: 10.1016/j.jhep.2020.08.027. Epub 2020 Aug 31. J Hepatol. 2021. PMID: 32882372 Free PMC article.

2

TNFalpha genotype affects TNFalpha release, insulin sensitivity and the severity of liver disease in HCV chronic hepatitis.

Valenti L, Pulixi E, Fracanzani AL, Dongiovanni P, Maggioni M, Orsatti A, Gianni C, Fargion S. Valenti L, et al. J Hepatol. 2005 Dec;43(6):944-50. doi: 10.1016/j.jhep.2005.05.035. Epub 2005 Jul 5. J Hepatol. 2005. PMID: 16143422

3

Alpha 1-antitrypsin mutations in NAFLD: high prevalence and association with altered iron metabolism but not with liver damage.

Valenti L, Dongiovanni P, Piperno A, Fracanzani AL, Maggioni M, Rametta R, Loria P, Casiraghi MA, Suigo E, Ceriani R, Remondini E, Trombini P, Fargion S. Valenti L, et al. Hepatology. 2006 Oct;44(4):857-64. doi: 10.1002/hep.21329. Hepatology. 2006. PMID: 17006922

4

Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.

Fracanzani AL, Valenti L, Bugianesi E, Andreoletti M, Colli A, Vanni E, Bertelli C, Fatta E, Bignamini D, Marchesini G, Fargion S. Fracanzani AL, et al. Among authors: valenti l. Hepatology. 2008 Sep;48(3):792-8. doi: 10.1002/hep.22429. Hepatology. 2008. PMID: 18752331

5

HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease.

Valenti L, Fracanzani AL, Bugianesi E, Dongiovanni P, Galmozzi E, Vanni E, Canavesi E, Lattuada E, Roviaro G, Marchesini G, Fargion S. Valenti L, et al. Gastroenterology. 2010 Mar;138(3):905-12. doi: 10.1053/j.gastro.2009.11.013. Epub 2009 Nov 18. Gastroenterology. 2010. PMID: 19931264 Free article.

6

Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease.

Dongiovanni P, Valenti L, Rametta R, Daly AK, Nobili V, Mozzi E, Leathart JB, Pietrobattista A, Burt AD, Maggioni M, Fracanzani AL, Lattuada E, Zappa MA, Roviaro G, Marchesini G, Day CP, Fargion S. Dongiovanni P, et al. Among authors: valenti l. Gut. 2010 Feb;59(2):267-73. doi: 10.1136/gut.2009.190801. Gut. 2010. PMID: 20176643

7

Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease.

Valenti L, Al-Serri A, Daly AK, Galmozzi E, Rametta R, Dongiovanni P, Nobili V, Mozzi E, Roviaro G, Vanni E, Bugianesi E, Maggioni M, Fracanzani AL, Fargion S, Day CP. Valenti L, et al. Hepatology. 2010 Apr;51(4):1209-17. doi: 10.1002/hep.23622. Hepatology. 2010. PMID: 20373368

8

I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease.

Valenti L, Alisi A, Galmozzi E, Bartuli A, Del Menico B, Alterio A, Dongiovanni P, Fargion S, Nobili V. Valenti L, et al. Hepatology. 2010 Oct;52(4):1274-80. doi: 10.1002/hep.23823. Hepatology. 2010. PMID: 20648474

9

Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease.

Valenti L, Nobili V, Fargion S. Valenti L, et al. N Engl J Med. 2010 Jul 8;363(2):194; author reply 195. N Engl J Med. 2010. PMID: 20653077 No abstract available.

10

Beta-globin mutations are associated with parenchymal siderosis and fibrosis in patients with non-alcoholic fatty liver disease.

Valenti L, Canavesi E, Galmozzi E, Dongiovanni P, Rametta R, Maggioni P, Maggioni M, Fracanzani AL, Fargion S. Valenti L, et al. J Hepatol. 2010 Nov;53(5):927-33. doi: 10.1016/j.jhep.2010.05.023. Epub 2010 Jul 25. J Hepatol. 2010. PMID: 20739079

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

586 results

Search Page

Filters